BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled drug trial aims to protect Kids' lungs after Life-Saving transplants
Disease control TerminatedThis study tested whether an inhaled medication (fluticasone/salmeterol) could improve lung function and prevent a serious lung complication called Bronchiolitis Obliterans in children who had received a stem cell transplant. The trial involved 35 children aged 6-17 whose lung fu…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Early halt for transplant lung disease drug trial
Disease control TerminatedThis early-stage study tested the safety of a drug called itacitinib for patients who developed a serious lung scarring condition (bronchiolitis obliterans) after a donor stem cell transplant. The trial aimed to see if the drug could help control this complication and improve pat…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC